2007
DOI: 10.1016/j.nucmedbio.2007.01.002
|View full text |Cite
|
Sign up to set email alerts
|

Assessment of Cu-ETS as a PET radiopharmaceutical for evaluation of regional renal perfusion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
33
0

Year Published

2008
2008
2019
2019

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 45 publications
(35 citation statements)
references
References 28 publications
2
33
0
Order By: Relevance
“…These radiopharmaceutical interactions with serum albumin are reversible, with radioTLC showing no evidence for chemical decomposition of the chelates, consistent with earlier findings [25,37]. Nevertheless, such albumin binding can be detrimental to drug delivery, particularly in applications requiring high first-pass tissue extraction of the pharmaceutical from blood, as is the case with radiotracer methods for probing regional tissue perfusion.…”
Section: Discussionsupporting
confidence: 84%
See 3 more Smart Citations
“…These radiopharmaceutical interactions with serum albumin are reversible, with radioTLC showing no evidence for chemical decomposition of the chelates, consistent with earlier findings [25,37]. Nevertheless, such albumin binding can be detrimental to drug delivery, particularly in applications requiring high first-pass tissue extraction of the pharmaceutical from blood, as is the case with radiotracer methods for probing regional tissue perfusion.…”
Section: Discussionsupporting
confidence: 84%
“…In this regard, the dramatically lower, and largely species-independent, binding of Cu-ETS to serum albumin [37] is expected to make Cu-ETS a more robust agent for evaluation of perfusion regardless of species. Cu-ETS remains under investigation as a tracer of myocardial and renal perfusion [22][23][24][25].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Laser Doppler [1], single photon computed tomography (SPECT) [2], multidetector computed tomography (CT) [3], magnetic resonance (MR) imaging [4] and positron emission tomography (PET) [5] all quantify tissue perfusion accurately but they are expensive and present some inherent limitations such as limited availability and patient exposure to radiation or nuclear tracers. Colour and power Doppler are limited by the low sensitivity to low-velocity flow in smaller vessels (<2 mm in diameter).…”
Section: Introductionmentioning
confidence: 99%